CVS Health Corporation (NYSE:CVS) shares were down 2.9% on Thursday . The company traded as low as $94.31 and last traded at $94.40, with a volume of 4,502,111 shares changing hands. The stock had previously closed at $97.17.

A number of research analysts recently weighed in on CVS shares. Citigroup Inc. lifted their price objective on shares of CVS Health Corporation from $105.00 to $115.00 and gave the company a “neutral” rating in a research note on Monday, May 9th. Credit Suisse Group AG reiterated a “buy” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a research note on Sunday, June 5th. Vetr lowered shares of CVS Health Corporation from a “strong-buy” rating to a “hold” rating and set a $95.44 price target for the company. in a research report on Monday, July 25th. Macquarie restated an “outperform” rating and set a $115.00 price target on shares of CVS Health Corporation in a research report on Thursday, May 5th. Finally, Jefferies Group boosted their price target on shares of CVS Health Corporation from $110.00 to $122.00 and gave the company a “buy” rating in a research report on Thursday, May 12th. Six equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. CVS Health Corporation has a consensus rating of “Buy” and an average price target of $113.02.

The stock has a 50-day moving average price of $96.49 and a 200-day moving average price of $98.53. The company has a market capitalization of $99.99 billion and a P/E ratio of 21.57.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.30 by $0.02. The firm earned $43.70 billion during the quarter, compared to analysts’ expectations of $44.28 billion. The firm’s quarterly revenue was up 17.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.19 EPS. On average, analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Thursday, July 21st were given a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend was Tuesday, July 19th.

Other hedge funds recently added to or reduced their stakes in the company. Fernwood Investment Management LLC increased its stake in CVS Health Corporation by 0.5% in the fourth quarter. Fernwood Investment Management LLC now owns 55,260 shares of the pharmacy operator’s stock valued at $5,403,000 after buying an additional 268 shares in the last quarter. American National Bank & Trust Co. VA increased its stake in CVS Health Corporation by 2.3% in the fourth quarter. American National Bank & Trust Co. VA now owns 20,823 shares of the pharmacy operator’s stock valued at $2,036,000 after buying an additional 471 shares in the last quarter. Tributary Capital Management LLC increased its stake in CVS Health Corporation by 5.3% in the fourth quarter. Tributary Capital Management LLC now owns 12,000 shares of the pharmacy operator’s stock valued at $1,173,000 after buying an additional 600 shares in the last quarter. D L Carlson Investment Group Inc. increased its stake in CVS Health Corporation by 1.2% in the fourth quarter. D L Carlson Investment Group Inc. now owns 54,129 shares of the pharmacy operator’s stock valued at $5,292,000 after buying an additional 625 shares in the last quarter. Finally, Violich Capital Management Inc. increased its stake in CVS Health Corporation by 0.5% in the fourth quarter. Violich Capital Management Inc. now owns 117,306 shares of the pharmacy operator’s stock valued at $11,469,000 after buying an additional 640 shares in the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.